BECTON DICKINSON & CO is 21.3x more valuable than NovoCure Ltd by market capitalization ($41.03 B vs $1.93 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | NVCR | BDX |
|---|---|---|
| Market cap | $1.93 B | $41.03 B |
| US-listed rank | #2120 | #371 |
| Revenue (latest FY) | $655.35M | $21.84B |
| Net income (latest FY) | -$136.23M | $1.68B |
| Net margin | -20.8% | 7.7% |
| P/E (trailing FY) | - | 24.5 |
| SEC filings | 1,138 | 3,027 |
BECTON DICKINSON & CO is 21.3x more valuable than NovoCure Ltd by market capitalization ($41.03 B vs $1.93 B).
In their latest fiscal years, NovoCure Ltd reported $655.35M in revenue while BECTON DICKINSON & CO reported $21.84B.
Full pages: NovoCure Ltd and BECTON DICKINSON & CO, or browse the full rankings.